Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

[Updated S3-Guideline Colitis ulcerosa. German Society for Digestive and Metabolic Diseases (DGVS) - AWMF Registry 021/009].

Authors; Collaborators:.

Z Gastroenterol. 2018 Sep;56(9):1087-1169. doi: 10.1055/a-0651-8174. Epub 2018 Sep 11. German.

2.

Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental Colitis.

Fröhling M, Tepasse P, Intemann J, Sambale M, Sherwood J, Paruzel P, Tiemeyer NM, Nowacki TM, Brückner M, Mennigen R, Lügering A, Echtermeyer F, Pap T, Stratis A, Bettenworth D.

Inflamm Bowel Dis. 2018 Jul 24. doi: 10.1093/ibd/izy248. [Epub ahead of print]

PMID:
30053064
3.

Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound.

Brückner M, Heidemann J, Nowacki TM, Cordes F, Stypmann J, Lenz P, Gohar F, Lügering A, Bettenworth D.

World J Gastroenterol. 2017 Apr 28;23(16):2899-2911. doi: 10.3748/wjg.v23.i16.2899.

4.

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.

Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group.

N Engl J Med. 2016 Nov 17;375(20):1946-1960.

5.

Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity.

Kucharzik T, Wittig BM, Helwig U, Börner N, Rössler A, Rath S, Maaser C; TRUST study group.

Clin Gastroenterol Hepatol. 2017 Apr;15(4):535-542.e2. doi: 10.1016/j.cgh.2016.10.040. Epub 2016 Nov 14.

PMID:
27856365
6.

The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.

Nowacki TM, Remaley AT, Bettenworth D, Eisenblätter M, Vowinkel T, Becker F, Vogl T, Roth J, Tietge UJ, Lügering A, Heidemann J, Nofer JR.

Br J Pharmacol. 2016 Sep;173(18):2780-92. doi: 10.1111/bph.13556. Epub 2016 Aug 11.

7.

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.

Schmidt C, Ahmad T, Tulassay Z, Baumgart DC, Bokemeyer B, Howaldt S, Stallmach A, Büning C; AEGIS Study Group.

Aliment Pharmacol Ther. 2016 Aug;44(3):259-70. doi: 10.1111/apt.13665. Epub 2016 May 29.

8.

Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort study.

Baumgart DC, Bokemeyer B, Drabik A, Stallmach A, Schreiber S; Vedolizumab Germany Consortium.

Aliment Pharmacol Ther. 2016 May;43(10):1090-102. doi: 10.1111/apt.13594. Epub 2016 Apr 1.

9.

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.

Teich N, Mohl W, Bokemeyer B, Bündgens B, Büning J, Miehlke S, Hüppe D, Maaser C, Klugmann T, Kruis W, Siegmund B, Helwig U, Weismüller J, Drabik A, Stallmach A; German IBD Study Group.

J Crohns Colitis. 2016 Jan;10(1):61-8. doi: 10.1093/ecco-jcc/jjv188. Epub 2015 Oct 13.

10.

Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.

Gasche C, Ahmad T, Tulassay Z, Baumgart DC, Bokemeyer B, Büning C, Howaldt S, Stallmach A; AEGIS Study Group.

Inflamm Bowel Dis. 2015 Mar;21(3):579-88. doi: 10.1097/MIB.0000000000000314.

11.

Respiratory complications in outpatient endoscopy with endoscopist-directed sedation.

Friedrich K, Scholl SG, Beck S, Gotthardt D, Stremmel W, Rex DK; bng-Study-Group, Sieg A.

J Gastrointestin Liver Dis. 2014 Sep;23(3):255-9. doi: 10.15403/jgld.2014.1121.233.kf1.

12.

Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation.

Bettenworth D, Reuter S, Hermann S, Weckesser M, Kerstiens L, Stratis A, Nowacki TM, Ross M, Lenze F, Edemir B, Maaser C, Pap T, Koschmieder S, Heidemann J, Schäfers M, Lügering A.

J Nucl Med. 2013 May;54(5):748-55. doi: 10.2967/jnumed.112.112623. Epub 2013 Mar 20.

13.

Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12.

Däbritz J, Langhorst J, Lügering A, Heidemann J, Mohr M, Wittkowski H, Krummenerl T, Foell D.

Inflamm Bowel Dis. 2013 May;19(6):1130-8. doi: 10.1097/MIB.0b013e318280b1cd.

PMID:
23377171
14.

Colon capsule endoscopy versus standard colonoscopy in assessing disease activity of ulcerative colitis: a prospective trial.

Meister T, Heinzow HS, Domagk D, Dortgolz A, Lenze F, Ross M, Domschke W, Lügering A.

Tech Coloproctol. 2013 Dec;17(6):641-6. doi: 10.1007/s10151-012-0965-8. Epub 2013 Jan 10.

PMID:
23307507
15.

Colonic patch and colonic SILT development are independent and differentially regulated events.

Baptista AP, Olivier BJ, Goverse G, Greuter M, Knippenberg M, Kusser K, Domingues RG, Veiga-Fernandes H, Luster AD, Lugering A, Randall TD, Cupedo T, Mebius RE.

Mucosal Immunol. 2013 May;6(3):511-21. doi: 10.1038/mi.2012.90. Epub 2012 Sep 19.

16.

Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation.

Lenze F, Wessling J, Bremer J, Ullerich H, Spieker T, Weckesser M, Gonschorrek S, Kannengiesser K, Rijcken E, Heidemann J, Luegering A, Schober O, Domschke W, Kucharzik T, Maaser C.

Inflamm Bowel Dis. 2012 Dec;18(12):2252-60. doi: 10.1002/ibd.22930. Epub 2012 Feb 22.

PMID:
22359277
17.

Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis.

Brückner M, Westphal S, Domschke W, Kucharzik T, Lügering A.

J Crohns Colitis. 2012 Mar;6(2):226-35. doi: 10.1016/j.crohns.2011.08.012. Epub 2011 Sep 23.

PMID:
22325177
18.

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease.

Nowacki TM, Bettenworth D, Ross M, Heidemann J, Lehmann PV, Lügering A.

Cells. 2012 Apr 23;1(2):35-50. doi: 10.3390/cells1020035.

19.

Collagen matrix-bound clotting factors (CMBCF) promote healing-associated events independent of factor XIII in an in vitro model.

Pohle T, Becker JC, Lügering A.

Wound Repair Regen. 2011 Nov;19(6):687-92. doi: 10.1111/j.1524-475X.2011.00732.x. Epub 2011 Oct 10.

PMID:
22092839
20.

The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function.

Bettenworth D, Buyse M, Böhm M, Mennigen R, Czorniak I, Kannengiesser K, Brzoska T, Luger TA, Kucharzik T, Domschke W, Maaser C, Lügering A.

Am J Pathol. 2011 Sep;179(3):1230-42. doi: 10.1016/j.ajpath.2011.05.013. Epub 2011 Jul 8.

Supplemental Content

Loading ...
Support Center